You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (11) |
Back to Search
Bioequivalence study of amodiaquine hydrochloride tablets
- In: SIG Bioavailability/Bioequivalence - Posters
- At: Beijing (China) (2007)
- Type: Poster
- Poster code: BB-P-044
- By: ZHONG, Dafang (Shanghai Institute of Materia Medica, Shanghai, China)
- Co-author(s): Chen, Xiaoyan (Shanghai Institute of Materia Medica, SHANGHAI, China)
Dai, Xiaojian (Shanghai Institute of Materia Medica, SHANGHAI, China)
Gao, Zhiwei (Shanghai Institute of Materia Medica, SHANGHAI, China) - Abstract:
OBJECTIVE To determine the bioequivalence of Amodiaquine Hydrochloride Tablets (test product) of Guilin Pharmaceutical Co., Ltd, China as compared to FlavoquineÂ[RSYMBOL] Tablets (reference product) of Laboratoire Aventis, France. METHODS The study was conducted as an open-label randomized, two-treatment, two-period, cross-over single-dose study..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026